Dr. Van Den Anker is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
111 Michigan Ave Nw
Washington, DC 20010Phone+1 202-884-5448
Education & Training
- Erasmus University Rotterdam Faculty of MedicineClass of 1983
Certifications & Licensure
- DC State Medical License 2002 - 2024
- OH State Medical License 2002 - 2005
- American Board of Pediatrics Pediatrics
Publications & Presentations
PubMed
- 81 citationsLong-Term Effects of Inhaled Budesonide for Bronchopulmonary Dysplasia.Dirk Bassler, Eric S. Shinwell, Mikko Hallman, Pierre-Henri Jarreau, Richard Plavka
The New England Journal of Medicine. 2018-01-10 - 34 citationsPopulation pharmacokinetic meta-analysis of individual data to design the first randomized efficacy trial of vancomycin in neonates and young infants.Evelyne Jacqz-Aigrain, Stéphanie Leroux, Alison H. Thomson, Karel Allegaert, Edmund V. Capparelli
The Journal of Antimicrobial Chemotherapy. 2019-08-01 - 89 citationsReviewing the WHO guidelines for antibiotic use for sepsis in neonates and childrenAline Fuchs, Julia Bielicki, Shrey Mathur, Mike Sharland, Johannes N. van den Anker
Paediatrics and International Child Health. 2018-05-23
Grant Support
- Optimizing The Use Of Methadone In Newborn InfantsNational Institute On Drug Abuse2010–2012
- Pediatric Toxicity And Efficacy In Long-Term Systemic Treatment With Anti-SenseEunice Kennedy Shriver National Institute Of Child Health &Human Development2011
- Metabolism And Toxicity Of Acetaminophen In Preterm InfantsEunice Kennedy Shriver National Institute Of Child Health &Human Development2010–2011
- Multiple Dose Pharmacokinetic Study Of Meropenem In Young Infants (91 Days)National Center For Research Resources2010
- Antimicrobial Pharmacokinetics In High Risk InfantsNational Center For Research Resources2010
- Clinical Trial: Optimizing Pain Treatment In Pre-Term NeonatesNational Center For Research Resources2009–2010
- Optimizing The Use Of Morphine In Preterm InfantsEunice Kennedy Shriver National Institute Of Child Health &Human Development2005–2009
- Washington D.C. Collaborative PpruEunice Kennedy Shriver National Institute Of Child Health &Human Development2004–2009
- Prevalence Of Proteinuria In Overweight AdolescentsNational Center For Research Resources2007–2008
- Optimizing Pain Treatment In Pre-Term NeonatesNational Center For Research Resources2005–2008
- Optimizing Pain Treatment In The Preterm InfantNational Center For Research Resources2004–2008
- Non-Invasive Assessment Of Opiate Analgesia In Children With Sickle Cell DiseaseEunice Kennedy Shriver National Institute Of Child Health &Human Development2006
- Network Of Pediatric Pharmacology Research UnitsEunice Kennedy Shriver National Institute Of Child Health &Human Development2002
- Pediatric Pharmacology Research UnitEunice Kennedy Shriver National Institute Of Child Health &Human Development2000–2001
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: